Screener
Arcutis Biotherapeutics, Inc. ARQT Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | (157) | 20 | (177) | 213 |
| Total other income (expense) | (1,284) | (933) | (3,397) | (1,185) |
| Income (loss) before income taxes | 15,145 | (15,544) | 3,943 | (40,325) |
| Provision for income taxes | 136 | 342 | 229 | 621 |
| Net income (loss) | $15,009 | $(15,886) | $3,714 | $(40,946) |
| Other comprehensive income (loss): | ||||
| Unrealized gain (loss) on marketable securities | (96) | (95) | (447) | (232) |
| Foreign currency translation adjustment | (46) | 200 | (165) | 204 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s income tax?
- Arcutis Biotherapeutics, Inc. (ARQT) reported income tax of $136K in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s income tax changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s income tax decreased by 60.2% year-over-year, from $342K to $136K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Arcutis Biotherapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude